Sign in

CIK 0001075880

  • Accelerated filer

KAZIA THERAPEUTICS LTD

Sign in to watch
Ticker
KZIA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
Australia
Entity type
Operating
Phone
+61 298780088
Business address
THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, Australia, 2000
Former names
NOVOGEN LTD
  1. 4 Open-market buy 10% owner bought 10,800 shares at an average $10.01 ($108,092)
  2. 4 Open-market buy 10% owner bought 11,800 shares at an average $9.83 ($115,973)
  3. 4 Open-market buy 10% owner bought 8,000 shares at an average $9.74 ($77,952)
  4. 4 Open-market buy 10% owner bought 7,800 shares at an average $9.78 ($76,262)
  5. 4 Open-market buy 10% owner bought 7,100 shares at an average $10.13 ($71,910)
  6. 4 Open-market buy 10% owner bought 6,800 shares at an average $10.31 ($70,083)
  7. 4 Open-market buy 10% owner bought 3,400 shares at $10.07 ($34,250)
  8. 4 Open-market buy 10% owner bought 7,400 shares at an average $9.97 ($73,801)
  9. 4 Open-market buy 10% owner bought 7,400 shares at an average $9.99 ($73,916)
  10. 4 Open-market buy 10% owner bought 7,100 shares at an average $10.11 ($71,784)
  11. 4 Open-market buy 10% owner bought 6,800 shares at an average $10.08 ($68,513)
  12. 4 Open-market buy 10% owner bought 4,000 shares at an average $9.90 ($39,598)
  13. 4 Open-market buy 10% owner bought 3,000 shares at $9.79 ($29,370)
  14. 4 Open-market buy 10% owner bought 5,200 shares at an average $9.29 ($48,300)
  15. 4 Open-market buy 10% owner bought 9,200 shares at an average $9.91 ($91,188)
  16. 4 Open-market buy 10% owner bought 6,000 shares at $9.95 ($59,700)
  17. 4 Open-market buy 10% owner bought 5,607 shares at an average $9.89 ($55,444)
  18. 4 Open-market buy 10% owner bought 963 shares at $9.86 ($9,495)
  19. 4 Open-market buy 10% owner bought 3,100 shares at an average $9.81 ($30,425)
  20. 4 Open-market buy 10% owner bought 8,361 shares at an average $9.88 ($82,594)

Page 4 of 5 · 84 filings